Total Payments
$1,482
2024 Payments
$1,482
Companies
10
Transactions
110
Payment Breakdown by Category
Food & Beverage$1,362 (91.9%)
Education$119.94 (8.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,362 | 108 | 91.9% |
| Education | $119.94 | 2 | 8.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $351.53 | 18 | $0 (2024) |
| Alkermes, Inc. | $293.14 | 18 | $0 (2024) |
| ABBVIE INC. | $264.76 | 30 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $233.91 | 21 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $136.31 | 12 | $0 (2024) |
| Lundbeck LLC | $100.54 | 5 | $0 (2024) |
| Indivior Inc. | $31.60 | 2 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $30.08 | 2 | $0 (2024) |
| Braeburn Inc. | $23.88 | 1 | $0 (2024) |
| Axsome Therapeutics, Inc. | $16.35 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,482 | 110 | Teva Pharmaceuticals USA, Inc. ($351.53) |
All Payment Transactions
110 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: CNS | ||||||
| 12/16/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $5.82 | General |
| Category: Neuroscience | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.83 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Neuropsychiatry | ||||||
| 12/04/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.78 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $28.54 | General |
| Category: CNS | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.74 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: CNS | ||||||
| 11/20/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $5.74 | General |
| Category: Neuroscience | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.77 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Neuropsychiatry | ||||||
| 11/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: CNS | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.76 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $10.13 | General |
| Category: CNS | ||||||
| 10/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.37 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $5.97 | General |
| Category: Neuropsychiatry | ||||||
| 10/24/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/23/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Neurology | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.77 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $8.79 | General |
| Category: CNS | ||||||
| 10/16/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $111.49 | General |
| 10/16/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: CNS | ||||||
About Maryalice Case, PMHNP
Maryalice Case, PMHNP is a Psychiatric/Mental Health healthcare provider based in Chickasha, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2023. The National Provider Identifier (NPI) number assigned to this provider is 1982310611.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Maryalice Case, PMHNP has received a total of $1,482 in payments from pharmaceutical and medical device companies, with $1,482 received in 2024. These payments were reported across 110 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,362).
Ad
Practice Information
- Specialty Psychiatric/Mental Health
- Location Chickasha, OK
- Active Since 01/26/2023
- Last Updated 03/03/2025
- Taxonomy Code 363LP0808X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1982310611
Products in Payments
- ARISTADA (Drug) $266.04
- VRAYLAR (Drug) $264.76
- INVEGA SUSTENNA (Drug) $233.91
- UZEDY (Drug) $148.83
- INGREZZA (Drug) $136.31
- ABILIFY ASIMTUFII (Drug) $114.20
- Austedo XR (Drug) $91.21
- PERSERIS (Drug) $31.60
- VIVITROL (Drug) $27.10
- BRIXADI (Drug) $23.88
- REXULTI (Drug) $16.42
- Auvelity (Drug) $16.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.